COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 1420: Articles 14191-14200  | Next

High frequency, high throughput quantification of SARS-CoV-2 RNA in wastewater settled solids at eight publicly owned treatment works in Northern California shows strong association with COVID-19 incidence
Wolfe, M. K., Topol, A., Knudson, A., Simpson, A., White, B. J., Vugia, D. J., Yu, A. T., Li, L., Balliet, M., Stoddard, P., Han, G. S., Wigginton, K. R., Boehm, A. B.
10.1101/2021.07.16.21260627 — Posted: 2021-07-20
Comparison of heat-inactivated and infectious SARS-CoV-2 across indoor surface materials shows comparable RT-qPCR viral signal intensity and persistence
Salido, R. A., Cantu, V. J., Clark, A. E., Leibel, S. L., Foroughishafiei, A., Saha, A., Hakim, A., Nouri, A., Lastrella, A. L., Castro-Martinez, A., Plascencia, A., Kapadia, B., Xia, B., Ruiz, C., Marotz, C., Maunder, D., Lawrence, E. S., Smoot, E. W., Eisner, E., Crescini, E. S., Kohn, L., Franco Vargas, L., Chacon, M., Betty, M., Machnicki, M., Wu, M. Y., Baer, N. A., Belda-Ferre, P., DeHoff, P., Saever, P., Ostrander, R. T., Tsai, R., Sathe, S., Aigner, S., Morgan, S. C., Ngo, T. T., Barber, T., Cheung, W., Carlin, A. F., Yeo, G. W., Laurent, L., Fielding-Miller, R., Knight, R.
10.1101/2021.07.16.452756 — Posted: 2021-07-20
Dique Filipeia: A rehabilitation protocol for non-intubated COVID-19 in-hospital patients
Frazao, M., Paiva, K. M., S, R. M. d. N., Menezes, F. d. S., Alves, L. A. d. S., Souza Rocha, A. I. S. d., Franca, E. E. T., Santos, A. d. C., Brasileiro-Santos, M. d. S.
10.1101/2021.07.19.21258787 — Posted: 2021-07-19
Key substitutions in the spike protein of SARS-CoV-2 variants can predict resistance to monoclonal antibodies, but other substitutions can modify the effects
Lusvarghi, S., Wang, W., Herrup, R., Neerukonda, S. N., Vassell, R., Bentley, L., Eakin, A. E., Erlandson, K. J., Weiss, C. D.
10.1101/2021.07.16.452748 — Posted: 2021-07-19
Rosin Soap Exhibits Virucidal Activity
Bell, S., Fairley, D. J., Kettunen, H., Vuorenmaa, J., Orte, J., Bamford, C. G. G., McGrath, J.
10.1101/2021.07.19.452918 — Posted: 2021-07-19
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants
Tada, T., Zhou, H., Samanovic, M. I., Dcosta, B. M., Cornelius, A., Mulligan, M. J., Landau, N. R.
10.1101/2021.07.19.452771 — Posted: 2021-07-19 Discussion: Onsite
Paradoxical Sex-Specific Patterns of Autoantibodies Response to SARS-CoV-2 Infection
Liu, Y., Ebinger, J. E., Mostafa, R., Budde, P., Gajewski, J., Walker, B., Joung, S., Wu, M., Bräutigam, M., Hesping, F., Schäfer, E., Schubert, A.-S., Zucht, H.-D., Braun, J., Melmed, G. Y., Sobhani, K., Arditi, M., Van Eyk, J. E., Cheng, S., Fert-Bober, J.
10.1101/2021.07.15.21260603 — Posted: 2021-07-19
Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
Afkhami, S., D'Agostino, M. R., Zhang, A., Stacey, H. D., Marzok, A., Kang, A., Singh, R., Bavananthasivam, J., Ye, G., Luo, X., Wang, F., Ang, J. C., Zganiacz, A., Sankar, U., Kazhdan, N., Koenig, J. F. E., Phelps, A., Jordana, M., Wan, Y., Mossman, K. L., Jeyanathan, M., Gillgrass, A., Medina, M. F. C., Smaill, F., Lichty, B. D., Miller, M. S., Xing, Z.
10.1101/2021.07.16.452721 — Posted: 2021-07-19
Unveiling Mutation Effects on the Structural Dynamics of the Main Protease from SARS-CoV-2 with Hybrid Simulation Methods
Philot, E. A., Gasparini, P., de Mattos, J. C., Magro, A., Torres-Bonfim, E., Quiroz, R. C. N., Klioussof, A., Perahia, D., Scott, A. L. B.
10.1101/2021.07.17.452787 — Posted: 2021-07-19
Integrative multi-omics landscape of non-structural protein 3 of severe acute respiratory syndrome coronaviruses
Shi, R., Feng, Z., Zhang, X.
10.1101/2021.07.19.452910 — Posted: 2021-07-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).